We are live on
!
Find out more
SP
Saranac Partners Portfolio holdings
AUM
$234M
1-Year Est. Return
14.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.4%
1 Year Est. Return
+14.11%
3 Year Est. Return
+62.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
-$296M
(-54%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-87.55%
Top 10 Holdings %
Top 10 Hldgs %
40.19%
Holding
237
New
7
Increased
43
Reduced
13
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$7.5M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$5.92M |
| 3 |
Amazon
AMZN
|
+$3.65M |
| 4 |
Microsoft
MSFT
|
+$2.91M |
| 5 |
Ametek
AME
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$8.08M |
| 2 |
Quanta Services
PWR
|
+$3.83M |
| 3 |
Broadcom
AVGO
|
+$1.59M |
| 4 |
AstraZeneca
AZN
|
+$876K |
| 5 |
L3Harris
LHX
|
+$600K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.75% |
| 2 | Healthcare | 14.92% |
| 3 | Financials | 14.06% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Industrials | 9.38% |
Similar funds
AL3A
BH
BWM
NTIC
TLA
CF
JRPCML
OAM
Saranac Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Saranac Partners held 237 positions worth $256M, down 54% from $552M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Saranac Partners withdrew a net $224M in Q4 2025, closing 160 positions and reducing 13 holdings. Its most notable exit was AstraZeneca, an estimated $876K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Saranac Partners opened a new position in Bank of America worth $7.81M.
- Saranac Partners's largest Q4 2025 buy was Bank of America: 141,810 shares worth $7.81M.
- Saranac Partners added most to Amazon in Q4 2025, an estimated $3.65M increase.
- Saranac Partners's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $8.08M.
- Saranac Partners fully exited AstraZeneca in Q4 2025, selling an estimated $876K.
- Saranac Partners's ten largest holdings make up 40% of its $256M portfolio in Q4 2025.
- Saranac Partners opened 7 new positions and closed 160 in Q4 2025.
- Saranac Partners's portfolio value fell 54% quarter-over-quarter to $256M.
Based on Saranac Partners's 13F filing for Q4 2025, filed 6 Feb 2026.